Dr. Mayur Patel M.D., is Independent Director of the Company. Since 1997, he has been a founding partner and a practicing physician with American Radiology Services (“ARS”) based in Baltimore, Maryland. In addition to practicing Radiology at three hospitals and several free standing imaging centers, Dr. Patel plays an active role in the administrative and financial functions of the group. He is an elected member of the board of directors of American Radiology Associates and in addition serves as the chairman of the finance committee. He is also a member of the Retirement, Quality Assurance and Operations committees. He has published many peer reviewed articles and also co-authored a book chapter in the field of Radiology. He has also lectured extensively both as an invited guest speaker and also at national meetings in the field of radiology and Molecular Imaging. He has held academic appointments as an Assistant Professor of Radiology at University of Vermont, School of Medicine (1989-1992) and at University of Maryland, School of Medicine (1989-2000). As a principal of ARS, he participated in the group’s corporate affiliation in the capital markets with Advent International (a global private equity group) and with CML Healthcare (a Canadian based medical diagnostics service provider).
Mayur Patel is 59, he's been the Independent Director of Oxbridge Re Ltd since 2013. There are no older and 6 younger executives at Oxbridge Re Ltd.
Mayur's mailing address filed with the SEC is C/O OXBRIDGE RE HOLDINGS LIMITED, 103 S. CHURCH ST., P.O. BOX 469, GRAND CAYMAN, E9, KY1-9006.
Over the last 10 years, insiders at Oxbridge Re Ltd have traded over $1,715,640 worth of Oxbridge Re Ltd stock and bought 541,334 units worth $2,693,772 . The most active insiders traders include Raymond E Cabillot, Allan S. Martin a Sanjay Madhu. On average, Oxbridge Re Ltd executives and independent directors trade stock every 190 days with the average trade being worth of $135,375. The most recent stock trade was executed by Allan S. Martin on 7 August 2024, trading 20,511 units of OXBR stock currently worth $63,174.
Oxbridge Re Ltd executives and other stock owners filed with the SEC include: